Tumor Biology

, Volume 35, Issue 1, pp 93–102 | Cite as

TaqI polymorphism of VDR gene contributes to breast cancer risk

  • Hua Wang
  • Wenjian Wang
  • Dongjie Yang
  • Shenming Wang
Research Article


Previous studies on the association of Vitamin D receptor (VDR) TaqI gene polymorphism with breast carcinogenesis have yielded inconsistent and inconclusive findings. The current meta-analysis was performed to provide a more precise assessment on the role of VDR TaqI polymorphism in breast cancer risk. 20 eligible case–control studies involving 9,055 cases and 10,516 controls were identified after a comprehensive literature search of the PubMed, Embase, Web of Science, and Wanfang databases. The pooled odds ratio (OR) with corresponding 95 % confidence interval (95 % CI) was calculated. Stratified analyses by ethnicity and study quality were conducted for further estimation. All statistical analyses were conducted by use of STATA (STATA Corporation, College Station, TX, Version 11.0). The overall ORs showed that the variant t allele and tt genotype were related to an increased risk of breast cancer (ORt vs. T = 1.05, 95 % CI 1.01–1.10, P OR = 0.025; ORtt vs. TT = 1.12, 95 % CI 1.03–1.23, P OR = 0.011; ORtt vs. Tt + TT = 1.10, 95 % CI 1.01–1.20, P OR = 0.023). Stratified analyses of studies in Caucasians and with high-quality further confirmed the results. However, no significant relationship was observed among Asians. This meta-analysis suggests that the VDR TaqI polymorphism confers risk effect on the breast cancer development, particularly in Caucasians.


Breast cancer Vitamin D receptor TaqI Polymorphisms Meta-analysis 



This work was supported by the Provincial Natural Science Foundation (S2012040006956).

Conflict of interests



  1. 1.
    Arriagada G, Paredes R, van Wijnen AJ, Lian JB, van Zundert B, Stein GS, et al. 1alpha,25-dihydroxy vitamin D(3) induces nuclear matrix association of the 1alpha,25-dihydroxy vitamin D(3) receptor in osteoblasts independently of its ability to bind DNA. J Cell Physiol. 2010;222:336–46.PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Wu S, Sun J. Vitamin D, vitamin D receptor, and macroautophagy in inflammation and infection. Discov Med. 2011;11:325–35.PubMedCentralPubMedGoogle Scholar
  3. 3.
    Holick MF. Vitamin D, and sunlight: strategies for cancer prevention and other health benefits. Clin J Am Soc Nephrol. 2008;3:1548–54.PubMedCrossRefGoogle Scholar
  4. 4.
    Singh A, Kamen DL. Potential benefits of vitamin D for patients with systemic lupus erythematosus. Derma Endocrinol. 2012;4:146–51.CrossRefGoogle Scholar
  5. 5.
    Whitfield GK, Hsieh JC, Jurutka PW, Selznick SH, Haussler CA, MacDonald PN, et al. Genomic actions of 1,25-dihydroxyvitamin D3. J Nutr. 1995;125:1690S–4S.PubMedGoogle Scholar
  6. 6.
    Di Rosa M, Malaguarnera L, Nicolosi A, Sanfilippo C, Mazzarino C, Pavone P, et al. Vitamin D3: an ever green molecule. Front Biosci (Schol Ed). 2013;5:247–60.PubMedCrossRefGoogle Scholar
  7. 7.
    Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, et al. The vitamin D hormone and its nuclear receptor: molecular actions and disease states. J Endocrinol. 1997;154(Suppl):S57–73.PubMedGoogle Scholar
  8. 8.
    Haussler MR, Jurutka PW, Hsieh JC, Thompson PD, Selznick SH, Haussler CA, et al. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone. Bone. 1995;17:33S–8S.PubMedCrossRefGoogle Scholar
  9. 9.
    Bai YH, Lu H, Hong D, Lin CC, Yu Z, Chen BC. Vitamin D receptor gene polymorphisms and colorectal cancer risk: a systematic meta-analysis. World J Gastroenterol. 2012;18:1672–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Raimondi S, Johansson H, Maisonneuve P, Gandini S. Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis. 2009;30:1170–80.PubMedCrossRefGoogle Scholar
  11. 11.
    Coughlin SS, Hall IJ. A review of genetic polymorphisms and prostate cancer risk. Ann Epidemiol. 2002;12:182–96.PubMedCrossRefGoogle Scholar
  12. 12.
    Vuolo L, Di Somma C, Faggiano A, Colao A. Vitamin D and cancer. Front Endocrinol (Lausanne). 2012;3:58.Google Scholar
  13. 13.
    Tang C, Chen N, Wu M, Yuan H, Du Y. Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysis. Breast Cancer Res Treat. 2009;117:391–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.PubMedCrossRefGoogle Scholar
  15. 15.
    Balasubramaniam SM, Rotti SB, Vivekanandam S. Risk factors of female breast carcinoma: a case control study at Puducherry. Indian J Cancer. 2013;50:65–70.PubMedCrossRefGoogle Scholar
  16. 16.
    Anothaisintawee T, Wiratkapun C, Lerdsitthichai P, Kasamesup V, Wongwaisayawan S, Srinakarin J, et al. Risk factors of breast cancer: a systematic review and meta-analysis. Asia Pac J Public Health. 2013.Google Scholar
  17. 17.
    Tang LY, Chen LJ, Qi ML, Su Y, Su FX, Lin Y, et al. Effects of passive smoking on breast cancer risk in pre/post-menopausal women as modified by polymorphisms of PARP1 and ESR1. Gene. 2013.Google Scholar
  18. 18.
    Romanowicz-Makowska H, Smolarz B, Zadrozny M, Westfal B, Baszczynski J, Polac I, et al. Single nucleotide polymorphisms in the homologous recombination repair genes and breast cancer risk in Polish women. Tohoku J Exp Med. 2011;224:201–8.PubMedCrossRefGoogle Scholar
  19. 19.
    Krupa R, Synowiec E, Pawlowska E, Morawiec Z, Sobczuk A, Zadrozny M, et al. Polymorphism of the homologous recombination repair genes RAD51 and XRCC3 in breast cancer. Exp Mol Pathol. 2009;87:32–5.PubMedCrossRefGoogle Scholar
  20. 20.
    Synowiec E, Stefanska J, Morawiec Z, Blasiak J, Wozniak K. Association between DNA damage, DNA repair genes variability and clinical characteristics in breast cancer patients. Mutat Res. 2008;648:65–72.PubMedCrossRefGoogle Scholar
  21. 21.
    Mishra DK, Wu Y, Sarkissyan M, Sarkissyan S, Chen Z, Shang X, et al. Vitamin D receptor gene polymorphisms and prognosis of breast cancer among African–American and Hispanic women. PLoS One. 2013;8:e57967.PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    Liu D, Zhang H, Zou T, Zhang Y, Yang Z, Ye T. Association between the genetic polymorphisms of Vitamin D receptor and sporadic breast cancer risk in Yunnan women of Han nationality. J Kunming Med Univer. 2011;32:91–4. Article in Chinese.Google Scholar
  23. 23.
    Engel LS, Orlow I, Sima CS, Satagopan J, Mujumdar U, Roy P, et al. Vitamin D receptor gene haplotypes and polymorphisms and risk of breast cancer: a nested case–control study. Cancer Epidemiol Biomarker Prev. 2012;21:1856–67.CrossRefGoogle Scholar
  24. 24.
    Huang Y, Lu H, Bai Y, Chen Y, Zeng Y, Pan Y. Relationship between genptypes and haplotypes of Vitamin D receptor gene and breast cancer risk. Zhonghua Liu Xing Bing Xue Za Zhi. 2012;41:89–92. Article in Chinese.Google Scholar
  25. 25.
    Anderson LN, Cotterchio M, Cole DE, Knight JA. Vitamin D-related genetic variants, interactions with vitamin D exposure, and breast cancer risk among Caucasian women in Ontario. Cancer Epidemiol Biomarker Prev. 2011;20:1708–17.CrossRefGoogle Scholar
  26. 26.
    Gapska P, Scott RJ, Serrano-Fernandez P, Huzarski T, Byrski T, Kladny J, et al. Vitamin D receptor variants and breast cancer risk in the Polish population. Breast Cancer Res Treat. 2009;115:629–33.PubMedCrossRefGoogle Scholar
  27. 27.
    Chakraborty A, Mishra AK, Soni A, Regina T, Mohil R, Bhatnagar D, et al. Vitamin D receptor gene polymorphism(s) and breast cancer risk in north Indians. Cancer Detect Prev. 2009;32:386–94.PubMedCrossRefGoogle Scholar
  28. 28.
    Abbas S, Nieters A, Linseisen J, Slanger T, Kropp S, Mutschelknauss EJ, et al. Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk. Breast Cancer Res. 2008;10:R31.PubMedCentralPubMedCrossRefGoogle Scholar
  29. 29.
    McCullough ML, Stevens VL, Diver WR, Feigelson HS, Rodriguez C, Bostick RM, et al. Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case–control study. Breast Cancer Res. 2007;9:R9.PubMedCentralPubMedCrossRefGoogle Scholar
  30. 30.
    John EM, Schwartz GG, Koo J, Wang W, Ingles SA. Sun exposure, vitamin D receptor gene polymorphisms, and breast cancer risk in a multiethnic population. Am J Epidemiol. 2007;166:1409–19.PubMedCrossRefGoogle Scholar
  31. 31.
    Sillanpaa P, Hirvonen A, Kataja V, Eskelinen M, Kosma VM, Uusitupa M, et al. Vitamin D receptor gene polymorphism as an important modifier of positive family history related breast cancer risk. Pharmacogenetics. 2004;14:239–45.PubMedCrossRefGoogle Scholar
  32. 32.
    Buyru N, Tezol A, Yosunkaya-Fenerci E, Dalay N. Vitamin D receptor gene polymorphisms in breast cancer. Exp Mol Med. 2003;35:550–5.PubMedCrossRefGoogle Scholar
  33. 33.
    Newcomb PA, Kim H, Trentham-Dietz A, Farin F, Hunter D, Egan KM. Vitamin D receptor polymorphism and breast cancer risk. Cancer Epidemiol Biomarker Prev. 2002;11:1503–4.Google Scholar
  34. 34.
    Hou MF, Tien YC, Lin GT, Chen CJ, Liu CS, Lin SY, et al. Association of vitamin D receptor gene polymorphism with sporadic breast cancer in Taiwanese patients. Breast Cancer Res Treat. 2002;74:1–7.PubMedCrossRefGoogle Scholar
  35. 35.
    Cui J, Shen K, Shen Z, Jiang F, Shen F. Relationship of vitamin D receptor polymorphism with breast cancer. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2001;18:286–8.PubMedGoogle Scholar
  36. 36.
    Lundin AC, Soderkvist P, Eriksson B, Bergman-Jungestrom M, Wingren S. Association of breast cancer progression with a vitamin D receptor gene polymorphism South-East Sweden Breast Cancer Group. Cancer Res. 1999;59:2332–4.PubMedGoogle Scholar
  37. 37.
    Dunning AM, McBride S, Gregory J, Durocher F, Foster NA, Healey CS, et al. No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer. Carcinogenesis. 1999;20:2131–5.PubMedCrossRefGoogle Scholar
  38. 38.
    Curran JE, Vaughan T, Lea RA, Weinstein SR, Morrison NA, Griffiths LR. Association of A vitamin D receptor polymorphism with sporadic breast cancer development. Int J Cancer. 1999;83:723–6.PubMedCrossRefGoogle Scholar
  39. 39.
    Salanti G, Amountza G, Ntzani EE, Ioannidis JP. Hardy–Weinberg equilibrium in genetic association studies: an empirical evaluation of reporting, deviations, and power. Eur J Hum Genet. 2005;13:840–8.PubMedCrossRefGoogle Scholar
  40. 40.
    Cochran WG. The comparison of percentages in matched samples. Biometrika. 1950;37:256–66.PubMedGoogle Scholar
  41. 41.
    Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.PubMedCrossRefGoogle Scholar
  42. 42.
    Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.PubMedGoogle Scholar
  43. 43.
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.PubMedCrossRefGoogle Scholar
  44. 44.
    Stuck AE, Rubenstein LZ, Wieland D. Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ. 1998;316:469. author reply 70–1.PubMedCrossRefGoogle Scholar
  45. 45.
    Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.PubMedCrossRefGoogle Scholar
  46. 46.
    Fang Y, van Meurs JB, D’Alesio A, Jhamai M, Zhao H, Rivadeneira F, et al. Promoter and 3′-untranslated-region haplotypes in the vitamin D receptor gene predispose to osteoporotic fracture: the Rotterdam study. Am J Hum Genet. 2005;77:807–23.PubMedCentralPubMedCrossRefGoogle Scholar
  47. 47.
    Crofts LA, Hancock MS, Morrison NA, Eisman JA. Multiple promoters direct the tissue-specific expression of novel N-terminal variant human vitamin D receptor gene transcripts. Proc Natl Acad Sci U S A. 1998;95:10529–34.PubMedCentralPubMedCrossRefGoogle Scholar
  48. 48.
    Carlberg C, Dunlop TW. The impact of chromatin organization of vitamin D target genes. Anticancer Res. 2006;26:2637–45.PubMedGoogle Scholar
  49. 49.
    Whitfield GK, Remus LS, Jurutka PW, Zitzer H, Oza AK, Dang HT, et al. Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol. 2001;177:145–59.PubMedCrossRefGoogle Scholar
  50. 50.
    Yazici D, Yavuz D, Tarcin O, Sancak S, Deyneli O, Akalin S. Vitamin D receptor gene ApaI, TaqI, FokI and BsmI polymorphisms in a group of Turkish patients with Hashimoto's thyroiditis. Minerva Endocrinol. 2013;38:195–201.PubMedGoogle Scholar
  51. 51.
    Li L, Wu B, Liu JY, Yang LB. Vitamin D Receptor Gene Polymorphisms and type 2 diabetes: a meta-analysis. Arch Med Res. 2013;44:235–41.PubMedCrossRefGoogle Scholar
  52. 52.
    Stefanic M, Rucevic I, Barisic-Drusko V. Meta-analysis of vitamin D receptor polymorphisms and psoriasis risk. Int J Dermatol. 2013;52:705–10.PubMedCrossRefGoogle Scholar
  53. 53.
    Szyszka P, Zmijewski MA, Slominski AT. New vitamin D analogs as potential therapeutics in melanoma. Expert Rev Anticancer Ther. 2012;12:585–99.PubMedCentralPubMedCrossRefGoogle Scholar
  54. 54.
    Touvier M, Chan DS, Lau R, Aune D, Vieira R, Greenwood DC, et al. Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomarker Prev. 2011;20:1003–16.CrossRefGoogle Scholar
  55. 55.
    Habuchi T, Suzuki T, Sasaki R, Wang L, Sato K, Satoh S, et al. Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population. Cancer Res. 2000;60:305–8.PubMedGoogle Scholar
  56. 56.
    Tozlu S, Girault I, Vacher S, Vendrell J, Andrieu C, Spyratos F, et al. Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach. Endocr Relat Cancer. 2006;13:1109–20.PubMedCrossRefGoogle Scholar
  57. 57.
    Dorjgochoo T, Delahanty R, Lu W, Long J, Cai Q, Zheng Y, et al. Common genetic variants in the vitamin D pathway including genome-wide associated variants are not associated with breast cancer risk among Chinese women. Cancer Epidemiol Biomarker Prev. 2011;20:2313–6.CrossRefGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2013

Authors and Affiliations

  • Hua Wang
    • 1
  • Wenjian Wang
    • 2
  • Dongjie Yang
    • 3
  • Shenming Wang
    • 1
  1. 1.Division of Vascular, Thyroid and Breast Surgery, First Affiliated HospitalSun Yat-sen UniversityGuangzhouChina
  2. 2.Laboratory of Department of Surgery, First Affiliated HospitalSun Yat-sen UniversityGuangzhouChina
  3. 3.Division of Gastrointestinal and Pancreatic Surgery, First Affiliated HospitalSun Yat-sen UniversityGuangzhouChina

Personalised recommendations